The cost of treating community-acquired pneumonia
The cost of treating community-acquired pneumonia
复制标题
DOI：
10.1016/s0149-2918(98)80144-6
复制
发表时间：
1998-07-01
影响因子：
3.2
通讯作者：
Popovian, R
中科院分区：
文献类型：
--
作者：
Niederman, MS;McCombs, JS;Popovian, R
社区获得性肺炎（CAP）每年平均有450万人次到医生办公室、急诊室和门诊就诊。然而，很少有研究使用国家数据的成本治疗CAP。如果没有这些数据，就很难评估是否需要新的疗法和治疗策略来改善患者的预后。我们进行了一项回顾性分析的基础上，国家发病率数据和支付索赔数据的患者接受治疗的CAP，以评估提供服务的频率和医疗保健系统的成本。根据国际疾病分类第9版，根据CAP的初步诊断选择记录进行研究。发病率数据来自国家健康和营养调查III。医疗保险是年龄大于或等于65岁的患者的主要数据来源。来自国家卫生保健成本和利用项目、国家门诊医疗保健调查和国家医院门诊医疗保健调查的数据被用来确定老年患者的治疗成本。
Community-acquired pneumonia (CAP) is responsible for an average of 4.5 million visits annually to physicians' offices, emergency departments, and outpatient clinics. However, there have been few studies using national data on the costs of treating CAP. Without such data, it is difficult to assess whether new therapies and treatment strategies are needed to improve patient outcomes. We conducted a retrospective analysis based on national incidence data and paid claims data for patients treated for CAP to assess the frequency of services rendered and costs to the health-care system. Records were selected for the study based on a primary diagnosis of CAP according to the International Classification of Diseases, 9th Revision. Incidence data were derived from the National Health and Nutrition Examination Survey III. Medicare was the primary source of data for patients aged greater than or equal to 65 years. Data from the National Health-care Cost and Utilization Project, the National Ambulatory Medical Care Survey, and the National Hospital Ambulatory Medical Care Survey were used to determine the cost of treating patients aged